SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study-Reference-Cited by-同舟云学术

SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study

Published:2016-04-06 Issue:3 Volume:31 Page:252-255
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Davies Simon J. C.¹²,Mulsant Benoit H.¹²³,Flint Alastair J.²⁴,Meyers Barnett S.⁵,Rothschild Anthony J.⁶,Whyte Ellen M.⁷,Kirshner Margaret M.⁸,Sorisio Denise⁷,Pollock Bruce G.¹²³,Bies Robert R.¹³⁹,

Affiliation:

1. Centre for Addiction and Mental Health; Toronto Canada

2. Department of Psychiatry; University of Toronto; Toronto Canada

3. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health; Toronto Canada

4. Department of Psychiatry; University Health Network; Toronto Canada

5. Weill Medical College of Cornell University and New York Presbyterian Hospital; New York NY USA

6. University of Massachusetts Medical School and University of Massachusetts Memorial Health Care; Worcester MA USA

7. Western Psychiatric Institute and Clinic, Department of Psychiatry; University of Pittsburgh School of Medicine; Pittsburgh PA USA

8. Department of Medicine; University of Pittsburgh School of Medicine; Pittsburgh PA USA

9. Indiana Clinical and Translational Sciences Institute (CTSI); Indianapolis IN USA

Funder

STOP-PD

US Public Health Service

National Institute of Mental Health

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference13 articles.

1. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology;Baldwin;J Psychopharmacol,2014

2. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis;Cipriani;Lancet,2009

3. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines;Cleare;J Psychopharmacol,2015

4. The impact of sertraline co-administration on the pharmacokinetics of olanzapine: a population pharmacokinetic analysis of the STOP-PD;Davies;Clin Pharmacokinet,2015

5. Clinical pharmacokinetics of sertraline;DeVane;Clin Pharmacokinet,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based prediction of sertraline concentration in patients with depression through therapeutic drug monitoring;Frontiers in Pharmacology;2024-03-06

2. Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder;Comprehensive Psychiatry;2022-05

3. Prediction of steady-state plasma concentrations of olanzapine in Chinese Han in patients based on a retrospective population pharmacokinetic model;Tropical Journal of Pharmaceutical Research;2021-12-13

4. Basic paradigms of antidepressants use in real clinical practice;Medical alphabet;2021-01-14

5. PharmGKB summary: sertraline pathway, pharmacokinetics;Pharmacogenetics and Genomics;2020-02